InvestorsHub Logo
Followers 2
Posts 105
Boards Moderated 0
Alias Born 10/18/2019

Re: None

Friday, 12/06/2019 8:07:08 AM

Friday, December 06, 2019 8:07:08 AM

Post# of 17446
“The positive results for the AURORA Phase III study of voclosporin is the news the lupus community has been waiting for and represents a remarkable breakthrough in efforts to bring a better quality of life for the more than five million people worldwide living with lupus,” Stevan Gibson, CEO of the Lupus Foundation of America, said in a statement.

strong endorsement
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News